por
John R. Fischer, Senior Reporter | October 22, 2018
From the October 2018 issue of HealthCare Business News magazine
One approach to ensure such standards are met has been the introduction of XR-29, requiring CT facilities to implement processes to record and assess the exposure of their doses to keep them within reasonable ranges. In effect, its use has raised accountability among providers in their administration of radiation and efforts to optmize dose delivery.
Understanding the full functions and uses of current developing technologies such as AI as well as technique is crucial says Frush, who sees them as integral parts in the calibration and delivery of correct dosage in the coming years.
Ad Statistics
Times Displayed: 11075
Times Visited: 14 Final days to save an extra 10% on Imaging, Ultrasound, and Biomed parts web prices.* Unlimited use now through September 30 with code AANIV10 (*certain restrictions apply)
“We need to promote the fact that CT has saved countless lives by continuing to question how we are going to make sure dose is right for the examination. I think we can look at advances with AI and how we are beginning to leverage that in terms of being able to assess image quality. We’re also evolving to have organ dose estimations now supplant what we typically have had, which is CT dose index volume (CTDIvol) and size-specific dose estimation (SSDE). Having this more granular, organ-based dose information for each patient’s scan can also enhance the dose component of a comprehensive CT performance monitoring program.”
Back to HCB News
